Company Registered Plan Private Investments Inc.
Equities
LXGTF
CA5290204067
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -90.00% | +900.00% | -.--% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Donald McInnes
CEO | Chief Executive Officer | 60 | 20-04-15 |
Bryan Disher
DFI | Director of Finance/CFO | 66 | 16-12-20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Bryan Disher
DFI | Director of Finance/CFO | 66 | 16-12-20 |
Tamara Manuel
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 23,669,560 | 0 | 0 | 13.79 % |
Stock B | 1 | 3,786,840 | 3,785,340 ( 99.96 %) | 0 |
Company contact information
Lexington Biosciences, Inc.
1055 West Hastings Street Suite 1900
V6E 2E9, Vancouver
+
Sector
1st Jan change | Capi. | |
---|---|---|
-.--% | 27 | |
-6.50% | 178B | |
-1.17% | 107B | |
-2.51% | 67.04B | |
-7.58% | 47.23B | |
+11.45% | 44.62B | |
+9.25% | 42.5B | |
+14.58% | 29.99B | |
+15.97% | 25.22B | |
-7.40% | 24.14B |
- Stock Market
- Equities
- LXGTF Stock
- Company Registered Plan Private Investments Inc.